WaferGen Bio-systems (WGBS) has risen sharply, recording gains of 8.61% in the past 4 weeks. However, the stock has corrected -27.09% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 7.5% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
The stock has recorded a 20-day Moving Average of 12.09% and the 50-Day Moving Average is 2.61%. WaferGen Bio-systems (NASDAQ:WGBS): stock turned positive on Friday. Though the stock opened at $0.8805, the bulls momentum made the stock top out at $0.8888 level for the day. The stock recorded a low of $0.8401 and closed the trading day at $0.8822, in the green by 0.25%. The total traded volume for the day was 1,026,884. The stock had closed at $0.88 in the previous days trading.
The company Insiders own 5.78% of WaferGen Bio-systems shares according to the proxy statements. Institutional Investors own 8.11% of WaferGen Bio-systems shares.
WaferGen Bio-systems, Inc. is engaged in the development of systems for gene expression quantification, genotyping and stem cell research. The Company is focused on the development, manufacture and marketing of its SmartChip System, a genetic analysis platform used for profiling and validating molecular biomarkers in the life sciences and pharmaceutical drug discovery industries. The Companys SmartChip System provides a range of capabilities, including messenger ribonucleic acid, microRNA and long non-coding ribonucleic acid (RNA) expression level measurement, as well as single nucleotide polymorphism genotyping. The Companys products include Gene Expression Technology, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation. It has launched its first generation SmartChip 5K System, which is a real-time polymerase chain reaction tool. It has launched the SmartChip MyDesign System, which is the second-generation instrument with upgraded capabilities.